The Nasdaq Biotech group experienced a pretty epic collapse after it made an all-time high in July 2015.  From its high to its recent low this past June, the group fell 40%.  Since June 27th, however, Biotech has surged, rallying 22.8% through trading earlier this morning.  We just sent our paid subscribers our Chart of the Day analyzing Biotech’s recent action and how long this run higher could potentially last.  To see the report, please start a 14-day free trial to Bespoke’s paid research below.



Print Friendly, PDF & Email